Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL

被引:0
|
作者
Calabresi, L
Tedeschi, G
Treu, C
Ronchi, S
Galbiati, D
Airoldi, S
Sirtori, CR
Marcel, Y
Franceschini, G
机构
[1] Univ Milan, Dept Pharmacol Sci, Ctr E Grossi Paoletti, I-20133 Milan, Italy
[2] Univ Milan, Inst Vet Physiol & Biochem, I-20133 Milan, Italy
[3] Univ Ottawa, Inst Heart, Lipoprot & Atherosclerosis Grp, Ottawa, ON K1Y 4WY, Canada
关键词
limited proteolysis; protein conformation; apolipoprotein A-I-Milano;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The apolipoprotein A-I-Milano (apoA-I-M) is a molecular variant of apoA-I characterized by the Arg(173)--> Cys substitution, leading to the formation of homodimers A-I-M/A-I-M. Upon interaction with palmitoyloleoylphosphatidylcholine, A-I-M/A-I-M forms only two species of reconstituted HDL (rHDL) particles, with diameters of 7.8 and 12.5 nm, We used limited proteolysis to analyze the conformation of A-I-M/A-I-M in the two rHDL particles, in comparison with that of apoA-I in rHDL of similar size, ApoA-I in the small, 7.8-nm rHDL is degraded to a greater extent (50% after 6 h) than in the large rHDL (< 10% degraded after 6 h). The protease susceptibility of A-I-M/A-I-M in small and large rHDL is instead remarkably the same, with A-I-M/A-I-M being much more sensitive to proteolytic digestion (50% degraded after 10 min) than apoA-I, The identification of the proteolytic fragments by immunoblotting, N-terminal sequencing, and molecular mass determination, shows that the N-terminus of both proteins is resistant to proteolysis, with six cleavage sites located in the central and carboxy-terminal portions of the molecules. Cleavage in the middle of apoA-I occurs at distinct sites in 7.8-nm (Lys(118)) and 12.7-nm (Arg(123)) rHDL, indicating a different conformation in small and large rHDL particles. The A-I-M/A-I-M instead adopts a unique and identical conformation in small and large rHDL, with the carboxy-terminal portion of the molecule being remarkably more accessible to the proteases than in apoA-I, This suggests the presence of a novel carboxy-terminal domain in A-I-M/A-I-M, not organized in a compact structure and not shared by wild-type apoA-I, which may account for the unique functional properties of A-I-M/A-I-M. - Calabresi, L., G. Tedeschi, C. Treu, S. Ronchi, D. Galbiati, S. Airoldi, C. R. Sirtori, E Marcel, and G. Franceschini. Limited proteolysis of a disulfide-linked apoA-I dimer in reconstituted HDL.
引用
收藏
页码:935 / 942
页数:8
相关论文
共 50 条
  • [21] Preparation and crystallization of the disulfide-linked HLA-G dimer
    Shiroishi, Mitsunori
    Kohda, Daisuke
    Maenaka, Katsumi
    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS, 2006, 1764 (05): : 985 - 988
  • [22] MOLECULAR-PROPERTIES OF MAJOR APOPROTEINS (APOA-I AND APOA-II) OF HUMAN HDL
    GWYNNE, J
    BREWER, HB
    EDELHOCH, H
    FEDERATION PROCEEDINGS, 1974, 33 (05) : 1585 - 1585
  • [23] Circulating HDL levels control hypothalamic astrogliosis via apoA-I
    Goetz, Anna
    Lehti, Maarit
    Donelan, Elizabeth
    Striese, Cynthia
    Cucuruz, Sebastian
    Sachs, Stephan
    Yi, Chun-Xia
    Woods, Stephen C.
    Wright, Samuel D.
    Mueller, Timo D.
    Tschoep, Matthias H.
    Gao, Yuanqing
    Hofmann, Susanna M.
    JOURNAL OF LIPID RESEARCH, 2018, 59 (09) : 1649 - 1659
  • [24] FAMILIAL HDL DEFICIENCY DUE TO MARKED HYPERCATABOLISM OF NORMAL APOA-I
    EMMERICH, J
    VERGES, B
    TAUVERON, I
    RADER, D
    SANTAMARINAFOJO, S
    SCHAEFER, J
    AYRAULTJARRIER, M
    THIEBLOT, P
    BREWER, HB
    ARTERIOSCLEROSIS AND THROMBOSIS, 1993, 13 (09): : 1299 - 1306
  • [25] HDL/apoA-I infusion for atherosclerosis management: an emerging therapeutic paradigm
    Shah, P. K.
    FUTURE LIPIDOLOGY, 2006, 1 (01): : 55 - 64
  • [26] ApoA-I is required for HDL anti-atherogenic function in vivo
    Moore, R
    Navab, M
    Hama, S
    Zimetti, F
    Rothblat, GH
    Rader, DJ
    ATHEROSCLEROSIS SUPPLEMENTS, 2005, 6 (01) : 42 - 42
  • [27] Activation of lecithin:cholesterol acyltransferase by HDL ApoA-I central helices
    Sorci-Thomas, Mary G.
    Bhat, Shaila
    Thomas, Michael J.
    CLINICAL LIPIDOLOGY, 2009, 4 (01) : 113 - 124
  • [28] The role of apoA-I helices 7 and 8 in HDL subclass formation
    Reschly, E
    Reardon, CA
    Getz, GS
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (04) : 671 - 671
  • [29] ApoE and ApoCIII Interact to Modulate the Metabolism of HDL ApoA-I in Humans
    Morton, Allyson
    Mendivil, Carlos O.
    Wang, Liyun
    Furtado, Jeremy D.
    Sacks, Frank M.
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2016, 36
  • [30] Associations between the HDL-C/ApoA-I ratio and fasting glucose levels differ by glucose deciles, HDL-C/ApoA-I ratio ranges and sex
    Zhang, Yuetao
    Wang, Yue
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2022, 190